BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19202442)

  • 1. Generation of donor-specific regulatory T-cell function in kidney transplant patients.
    Hendrikx TK; van Gurp EA; Sewgobind VD; Mol WM; Schoordijk W; Klepper M; Velthuis JH; Geel A; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2009 Feb; 87(3):376-83. PubMed ID: 19202442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.
    Baan CC; Velthuis JH; van Gurp EA; Mol WM; Klepper M; Ijzermans JN; Weimar W
    Clin Transplant; 2007; 21(1):63-71. PubMed ID: 17302593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
    Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
    Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
    Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
    Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients.
    Velthuis JH; Hesselink DA; Hendrikx TK; van der Mast BJ; Klepper M; de Greef GE; Baan CC; Weimar W
    Transpl Immunol; 2007 Nov; 18(2):159-65. PubMed ID: 18005862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
    Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
    Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients.
    Wang Z; Fu XY; Shi BY; Qian YY; Xiao L; Bai HW
    Transplant Proc; 2009 Jun; 41(5):1574-6. PubMed ID: 19545682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
    Mittal SK; Sharma RK; Gupta A; Naik S
    Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation.
    Berglund D; Korsgren O; Lorant T; Schneider K; Tufveson G; Carlsson B
    Transpl Immunol; 2012 Jan; 26(1):27-33. PubMed ID: 21958749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T(H)17 versus Treg cells in renal transplant candidates: effect of a previous transplant.
    San Segundo D; López-Hoyos M; Fernández-Fresnedo G; Benito MJ; Ruiz JC; Benito A; Rodrigo E; Arias M
    Transplant Proc; 2008 Nov; 40(9):2885-8. PubMed ID: 19010136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients.
    Ardalan MR; Maljaei H; Shoja MM; Piri AR; Khosroshahi HT; Noshad H; Argani H
    Transplant Proc; 2007 May; 39(4):951-3. PubMed ID: 17524860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
    Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
    Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patients.
    Dijke IE; Velthuis JH; Balk AH; Korevaar SS; Maat AP; Weimar W; Baan CC
    J Heart Lung Transplant; 2006 Aug; 25(8):955-64. PubMed ID: 16890117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
    van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
    Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in renal transplantation and modulation by immunosuppression.
    López-Hoyos M; Segundo DS; Fernández-Fresnedo G; Marín MJ; González-Martín V; Arias M
    Transplantation; 2009 Aug; 88(3 Suppl):S31-9. PubMed ID: 19667959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.